Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

SHS: Medice Acquires Digital Health Pioneer Selfapy GmbH (2025-03-13)
Selfapy GmbH, a digital health pioneer in the field of mental health, has been acquired by MEDICE Health Family, the European market leader in ADHD therapy. As part of the transaction, the investors SHS Capital, Think.Health Ventures, IBB Ventures, and HTGF sold th...
Haya Therapeutics Appoints Richard Law as CBO (2025-03-13)
Former Exscientia executive who helped build the company and facilitate its merger with Recursion Pharmaceuticals joins to accelerate HAYA’s strategic business operations and partnering HAYA Therapeutics, SA, a biotechnology company pioneering precision RNA-...
Pierre Fabre Partners with Versant-created Red Ridge Bio AG (2025-03-12)
Pierre Fabre Laboratories and RedRidge Bio (“RedRidge”) today announced an exclusive R&D collaboration and license agreement to identify and develop biparatopic antibody (BPA) drug candidates against multiple targets. In line with Pierre Fabre Laboratories’ i...
New Roche Genentech Innovation Center Boston in Allston, MA (2025-03-07)
> The new center will be a hub for both Roche and Genentech, bringing together expertise in Cardiovascular, Renal, and Metabolism, as well as for data science and AI specialists to drive innovation in drug discovery and development > Roche will be the first to j...
Xund Solutions Raises €6m Pre-Series A Round (2025-03-05)
The investment, led by Lead Ventures and joined by J&T Ventures, strengthens XUND’s role in AI-powered healthcare. XUND will accelerate expansion in DACH and the UK, driven by increasing demand for certified solutions. By advancing MDR-certified solutions and ali...
CordenPharma to Invest >€500m in New Facility near Basel (2025-03-05)
> CordenPharma is making a record investment of >€1 billion over the next 3 years in building and / or expanding small, medium, and large peptide manufacturing facilities across Europe and the US. > In Switzerland, CordenPharma will invest >€500m to construc...
Epoch Biodesign: $17.3m Series A Led by Extantia Capital (2025-03-05)
Epoch Biodesign, a company using enzymes to make recycled plastics cheaper and higher performing than virgin materials, today announced it has raised $18.3M in Series A capital in an oversubscribed round. The financing round was led by Extantia Capital, with partic...
Trimtech Therapeutics Raises £25m Seed Round for TPD (2025-03-05)
> Oversubscribed financing led by Cambridge Innovation Capital and SV Health Investors’ Dementia Discovery Fund with M Ventures and Pfizer Ventures joining > Investment will support further development of CNS penetrant therapeutics based on the Company’s TRI...
Momentum Biotechnologies Acquires Munich-based OmicScouts (2025-03-05)
Momentum Biotechnologies (“Momentum”), a contract research organization (“CRO”) specializing in mass spectrometry-based drug discovery, announced today that it has successfully completed the acquisition of OmicScouts GmbH (“OmicScouts”), a Munich-based ...
Qiagen Files TB Detection Complaint against bioMérieux (2025-03-03)
> QIAGEN files lawsuit against bioMérieux with German Unified Patent Court to protect key innovations in its QuantiFERON technology > QuantiFERON-TB Gold Plus plays a critical role in fighting the spread of TB worldwide QIAGEN N.V. (NYSE: QGEN; Frankfurt P...

» Show all News!

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

» Start here with the latest News!

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]